SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-031725
Filing Date
2022-12-12
Accepted
2022-12-12 16:22:14
Documents
1
Period of Report
2022-12-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167088011975647.html 4  
1 FORM 4 wf-form4_167088011975647.xml 4 3259
  Complete submission text file 0001628280-22-031725.txt   4733
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Issuer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 555 CALIFORNIA STREET SUITE 365 SAN FRANCISCO CA 94104
Business Address
NEIL GARRY ARTHUR (Reporting) CIK: 0001586785 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37590 | Film No.: 221457382